This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Company Statement: PHOENIX group strengthens its position considerably in one of the large European pharmaceutical markets.

( May 28, 2008, 16:44 GMT | Official Statement) -- ****************************************Mannheim, 29 May 2008 -The Mannheim pharmaceutical distributor acquires the CERP Lorraine Group’s French wholesale business. At yesterday's general meeting of CERP Lorraine on the sale to PHOENIX, the two companies began to put the transaction in motion. The takeover should be finalised in October. Both parties agreed to remain silent regarding the purchase price....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login